|Articles|April 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Low Testosterone Is Linked with Alzheimer's Disease

A study of 574 men participating in the Baltimore Longitudinal Study of Aging found that low levels of testosterone were connected with a greater risk of developing Alzheimer's disease. The participants were followed for 19 years, and their levels of free testosterone?the amount of testosterone circulating in the blood?were checked periodically. At the beginning of the study, none of the participants had Alzheimer's disease, but during the follow-up period 54 developed the disease.

It is not uncommon for levels of testosterone to decrease with age, but it was noted that levels had dropped dramatically in the men who developed Alzheimer's disease. In addition, for some participants this drop in testosterone was found 10 years before Alzheimer's disease was diagnosed.

Articles in this issue

over 21 years ago

RxPRODUCT NEWS PROFILE: Caduet

over 21 years ago

COMPOUNDING HOTLINE

over 21 years ago

Case Studies

over 21 years ago

Buddies Are Good for the Heart

over 21 years ago

Rage Is Connected to Stroke Risk

over 21 years ago

InnoLet

over 21 years ago

Colace/Peri-Colace

over 21 years ago

TampAlerT

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME